The third line of treatment for metastatic prostate cancer patients: Option or strategy?
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference40 articles.
1. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010
2. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011
3. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012
4. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010
5. Alpha emitter radium-223 and survival in metastatic prostate cancer;Parker;N Engl J Med,2013
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice;Medical Oncology;2022-07-14
2. A Phase Ib Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate Cancer;Clinical Cancer Research;2021-06-09
3. Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study;Clinical Cancer Research;2021-02-10
4. How the CARD trial has changed the cards on the table for metastatic castration resistant prostate cancer;Reports of Practical Oncology & Radiotherapy;2020-07
5. EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells;Cell Death & Disease;2019-10-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3